Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
Trials
; 23(1): 331, 2022 Apr 21.
Article
em En
| MEDLINE
| ID: mdl-35449015
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Acidente Vascular Cerebral
/
Insuficiência Renal Crônica
/
Infarto do Miocárdio
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article